Chronic fatigue syndrome: An immunological perspective

References

• Lloyd A, Hickie I, Wakefield D. Immunity and the patho-physiology of chronic fatigue syndrome. Ciba Foundation Symposium 1993; 173: 176–192
   PubMedGoogle Scholar
• Fukuda K, Straus S E, Hickie I, Sharpe M C, Dobbins J G, Komaroff A. The chronic fatigue syndrome: a comprehen sive approach to its definition and study. Annals of Internal Medicine 1994; 121: 953–959
   PubMed Web of Science ®Google Scholar
• Dickinson C J. Chronic fatigue syndrome—aetiological aspects. European Journal of Clinical Investigation 1997; 27: 257–267
   PubMed Web of Science ®Google Scholar
• Hickie I, Lloyd A, Hadzi-Pavlovic D, Parker G, Bird K, Wakefield D. Can the chronic fatigue syndrome be defined by distinct clinical features. Psychological Medicine 1995; 25: 925–935
   PubMed Web of Science ®Google Scholar
• White P D, Thomas J M, Amess J, Grover S A, Kangro H O, Clare A W. The existence of a fatigue syndrome after glandular fever. Psychological Medicine 1995; 25: 907–916
   PubMed Web of Science ®Google Scholar
• Hotopf M, Noah N, Wessely S. Chronic fatigue and minor psychiatric morbidity after viral meningitis: a controlled study. Journal of Neurology, Neurosurgery and Psychiatry 1996; 60: 504–509
   PubMed Web of Science ®Google Scholar
• Hickie I B, Hooker A W, Hadzi-Pavlovic D, Bennett B K, Wilson A J, Lloyd A R. Fatigue in selected primary care set tings; sociodemographic and psychiatric correlates. Medical Journal of Australia 1996; 64: 585–588
   Google Scholar
• Kanton W, Walker E A. The relationship of chronic fatigue to psychiatric illness in community, primary care and tertiary care samples. Ciba Foundation Symposium 1993; 173: 193–204
   Google Scholar
• Wessely S, Chalder T, Hirscb S, Pawlikowska T, Wallace P, Wright D JM. Postinfectious fatigue: prospective cohort study in primary care. Lancet 1995; 345: 1333–1338
   PubMed Web of Science ®Google Scholar
• Daugherty S A, Henry B, Peterson D L, Swarts R L, Bastien S, Thomas R S. Chronic fatigue syndrome in northern Nevada. Reviews of Infectious Diseases 1991; 13: s39–s44
   PubMedGoogle Scholar
• Barker E, Fujimura S F, Fadem M B, Landay A L, Levy J A. Immunological abnornalities associated with chronic fatigue syndrome. Clinical Infectious Diseases 1994; 18: s136–s141
   PubMed Web of Science ®Google Scholar
• Konstantinov K, vonMikecz A, Buchwald D, Jones J, Gerace L, Tan E M. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. Journal of Clinical Investigations 1996; 98: 1888–1896
   PubMed Web of Science ®Google Scholar
• Chao C C, Janoff E N, Hu S, et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991; 3: 292–298
   PubMed Web of Science ®Google Scholar
• Renault P F, Hoofnagel J H. Side effects of alpha interferon. Seminars in Liver Disease 1989; 9: 213–277
   Google Scholar
• Hart B. Biological basis of the behaviour of sick animals. Neuroscience and Biobehavioral Reviews 1988; 12: 123–137
   PubMed Web of Science ®Google Scholar
• Dantzer R, Bluthe R M, Kent S., Kelly K W. Behavioural effects of cytokines. Interleukin-1 in the brain, N J Rothwell, R Dantzer. Pergamon Press, Oxford 1992
   Google Scholar
• Lloyd A, Abi Hanna D, Wakefield D. Interferon and myalgic encephalomyelitis. Lancet 1988; i: 471
   Google Scholar
• Lloyd A, Hickie I, Brockman A, Dwyer J, Wakefield D. Serum and cerebrospinal fluid cytokine levels in patients with chronic fatigue syndrome and control subjects. Journal of Infectious Diseases 1991; 164: 1023–1024
   PubMed Web of Science ®Google Scholar
• Lloyd A, Gandevia S, Brockman A, Hales J, Wakefield D. Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise. Clinical Infectious Diseases 1994; 18: s142–s146
   PubMedGoogle Scholar
• Linde A, Andersson B, Svenson S B, et al. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. Journal of Infectious Diseases 1992; 165: 994–1000
   PubMed Web of Science ®Google Scholar
• Patarca R, Klimas N C, Lugtendorf S, Antoni M, Fletcher M A. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clinical Infectious Diseases 1994; 18: s147–153
   PubMed Web of Science ®Google Scholar
• Lever A ML, Lewis D M, Bannister B A, Fry M, Berry N. Interferon production in postviral fatigue syndrome. Lancet 1988; i: 101
   Google Scholar
• Swanink C M, Vercoulen J HMM, Galama J MD, et al. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. Journal of Infectious Diseases 1996; 173: 460–463
   PubMed Web of Science ®Google Scholar
• Banks W A, Kastin A J, Gutierrez E G. Interleukin-I alpha in blood has direct access to cortical brain cells. Neuroscience Letters 1993; 163: 41–44
   PubMed Web of Science ®Google Scholar
• Hickey W F. T-lymphocyte entry and antigen recognition in the central nervous system. Psychoneuroimmunology, 2nd ed., R Ader, D L Felten, N Cohen. Academic Press, San Diego, CA 1991; 149–175
   Google Scholar
• Chung I Y, Benveniste E N. Tumor necrosis factor-alpha production by lipopolysaccharide, 1NF-gamma, and IL-I-beta. Journal of lmmunology 1990; 144: 2999–3007
   PubMed Web of Science ®Google Scholar
• Malipiero U V, Frei K, Fontana A. Production of hemopoietic colony-stimulating factors by astrocytes. Journal of Immunology 1990; 144: 3816–3821
   PubMed Web of Science ®Google Scholar
• Sharif S F, Hariri R J, Chang V A, Bark P S, Wang R S, Ghajar J BG. Human astrocyte production of tumor necrosis factor-alpha, interlekin-1 beta, and interleukin-6 following expo sure to lipopolysaccharide endotoxin. Neurological Research 1993; 15: 109–112
   Web of Science ®Google Scholar
• Smith C A, Davis T, Anderson D, et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248: 1019–1023
   PubMed Web of Science ®Google Scholar
• Schonbitz B, deKloet E R, Sutanto W, Holsboer F. Cellular localization of interleukin-6 mRNA and interleukin-6 receptor mRNA in rat brain. European Journal of Neuroscience 1993; 5: 1426–1435
   Google Scholar
• Shintani F, Kanba S, Nakaki T, et al. Interleukin-1 beta augments release of norepinepherine, dopamine, and serotonin in the rat anterior hypothalamus. Journal of Neuroscience 1993; 13: 3574–3581
   PubMed Web of Science ®Google Scholar
• Zalcman S, Green-Johnson J M, Murray L, Nance D M, Dyck D, Anisman H, Greebgerg A H. Cytokine-specific central monoamine alterations induced by interleukin-1,–2 and -6. Brain Research 1994; 643: 40–49
   PubMed Web of Science ®Google Scholar
• Oitzl M S, vanOers H, Schobitz B, de Kloet E R. Interleukin-1 beta hut not interleukin-6 impairs spatial navigation learning. Brain Research 1993; 613: 160–163
   Google Scholar
• Bianchi M, Ferrario P, Zonta N, Panerai A E. Effects of interleukin- 1 beta and interleukin-2 on amino acid levels in mouse cortex and hippocampus. Neuro Report 1995; 6: 1689–1692
   Google Scholar
• Epstein L G, Gendelman H E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenic mechanisms. Annals of Neurology 1993; 33: 429–436
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Fiers W. Is amyloidogenesis during Alzheimer's disease due to IL-1/IL-6 mediated ‘acute phase response’ in the brain?. Immunology Today 1991; 12: 217–219
   PubMedGoogle Scholar
• Chao C C, Hu S, Tsang M, et al. Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neural injury. Journal of Clinical Investigation 1992; 90: 1786–1793
   Google Scholar
• Choi D W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623–634
   PubMed Web of Science ®Google Scholar
• Fontana A, Constam D B, Frei K, Malipiero U, Pfister H W. Modulation of the immune response by transforming growth factor beta. International Archives of Allergy and Immunology 1992; 99: 1–7
   PubMed Web of Science ®Google Scholar
• Buchwald D, Cheney P R, Peterson D L, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpes virus type 6 infection. Annals of internal Medicine 1992; 116: 103–113
   PubMed Web of Science ®Google Scholar
• Ichise M, Salit I E, Abbey S E, et al. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nuclear Medicine Communications 1992; 13: 767–772
   PubMed Web of Science ®Google Scholar
• Ader R, Felten D L, Cohen N. Psychoneuroimmunology. Academic Press, San Diego, CA 1991
   Google Scholar